economybharat.com

We Can Cover You
Click here
Facebook Twitter Youtube
13
13

Bio

BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell OG_NewsReleaseCompanyLogo_92870.jpg

BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell

creativebharatgroup@gmail.com December 14, 2024
Mont-Saint-Guibert, Belgium & TOKYO, Japan:   BrightPath Bio (Tokyo Stock Exchange Growth 4594,...
Read More Read more about BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell